CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $4,842,000 | -14.9% | 244,673 | 0.0% | 4.86% | +5.3% |
Q1 2021 | $5,691,000 | +11.3% | 244,673 | -0.6% | 4.61% | +18.3% |
Q4 2020 | $5,113,000 | -10.8% | 246,036 | -7.1% | 3.90% | -13.9% |
Q3 2020 | $5,734,000 | -7.0% | 264,859 | +1.3% | 4.53% | +5.0% |
Q2 2020 | $6,163,000 | +70.5% | 261,491 | -17.8% | 4.31% | +21.3% |
Q1 2020 | $3,614,000 | – | 318,273 | – | 3.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |